ArticleJournal of gastroenterology and hepatology2021

Safety and effectiveness of ustekinumab in Crohn's disease: Interim results of post-marketing surveillance in Japan.

Seiji Yokoyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.